biomedicina slovenica


"Gliom" : 168

  1. Matjašič Alenka; Popović Mara; Matos Boštjan; Glavač Damjan
    Expression of LOC285758, a potential long non-coding biomarker, is methylation- dependent and correlates with glioma malignancy grade
    2017
  2. Komel Radovan
    GMB proteomic biomarkers identified by reverse proteomics and targeting with nanobodies
    2017
  3. Vranič Andrej; Koritnik Blaž; Markovič Božič Jasmina
    Awake craniotomy for left insular low-grade glioma removal on a patient with learning disabilities
    2017
  4. Strojnik Tadej; Duh Darja; Lah Turnšek Tamara
    Prevalence of neurotropic viruses in malignant glioma and their onco-modulatory potential
    2017
  5. Knez Miklič Maja; Bertok Sara; Avbelj Magdalena; Bratanič Nevenka
    Tumorji kromafinih celic
    [Chromaffin cell tumours]
    2015
  6. Vidak Marko; Rozman Damjana; Liović Mirjana; Komel Radovan
    Search of new glioblastoma stem cell markers by comparing microarrays data from the NCBI geo database, and experimental validation of those markers in glioma cell lines
    2016
  7. Vidak Marko; Rozman Damjana; Liović Mirjana; Komel Radovan
    Search of new glioblastoma stem cell markers by analysis of NCBI GEO datasets, and experimental validation of those markers in glioma cell lines
    2016
  8. Velnar Tomaž
    Molecular markers in oligodendrogliomas
    2016
  9. Reeves Chad
    Oligodendrogliomas (ODs)
    2016
  10. Mesti Tanja; Ocvirk Janja
    Malignant gliomas
    2016
  11. Jovchevska Ivana; Kočevar Nina; Muyldermans Serge; Kastelic Damjana; Komel Radovan
    Identification of human glioma cells protein markers using llama heavy chain antibody-derived nanobodies
    2013
  12. Jovchevska Ivana; Kočevar Nina; Kastelic Damjana; Komel Radovan
    Llama heavy-chain antibodies as means to identify protein markers for human glioma
    2013
  13. Strojnik Tadej; Røsland Gro Vatne; Sakariassen Per Oystein; Kavalar Rajko; Lah Turnšek Tamara
    Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival
    2007
  14. Soletti Rossana C.; Alves Tercia; Vernal Javier; Tarenzi Hernán; Anderluh Gregor; Borges Helena L.; Gabilan Nelson H.; Moura Neto Vivaldo
    Inhibition of MAPK/ERK, PKC and CaMKII signaling blocks cytolysin-induced human glioma cell death
    2010
  15. Suárez Carlos; Fernández-Alvarez Verónica; Neumann Hartmut P. H.; Boedeker Carsten C.; Offergeld Christian; Rinaldo Alessandra; Strojan Primož; Ferlito Alfio
    Modern trends in the management of head and neck paragangliomas
    2015
  16. Vidak Marko; Rozman Damjana; Komel Radovan
    Effects of flavonoids from food and dietary supplements on glial and glioblastoma multiforme cells
    2015
  17. Matjašič Alenka; Tajnik Mojca; Boštjančič Emanuela; Popović Mara; Matos Boštjan; Glavač Damjan
    Long non-coding RNAs, important in brain development, are aberrantly expressed in glioma
    2015
  18. Gole Boris; Huszthy Peter C.; Popović Mara; Jeruc Jera; Ardebili Seyed Yousef; Bjerkvig Rolf; Lah Turnšek Tamara
    The regulation of cysteine cathepsins and cystatins in human gliomas
    2012
  19. Strojnik Tadej; Kavalar Rajko
    Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in a chick embryo model
    2009
  20. Gole Boris; Duran Alonso Maria Beatriz; Lah Turnšek Tamara
    Protease invasiveness markers in GBM cells, U87 and CD133+ cells
    2009
  21. Mesti Tanja; Ebert Moltara Maja; Boc Marko; Reberšek Martina; Ocvirk Janja
    Bevacizumab and irinotecan in recurrent malignant glioma, a single institution experience
    2015
  22. Ocvirk Janja
    Anti-angiogenic therapy for malignant gliomas
    2009
  23. Briggs S.; Stevenson K.; Verbovšek Urška; Yin L.H.; Pilkington Geoffrey J.; Lah Turnšek Tamara; Fillmore H.L.
    Cathepsin K in an in vitro model of glioma angiogenesis
    2014
  24. Crocetti Emanuele; Primic-Žakelj Maja
    Epidemiology of glial and non-glial brain tumours in Europe
    2012
  25. Khan Zahidul; Piškur Jure
    Plant thymidine kinase 1
    2010
  26. Mesti Tanja; Ebert Moltara Maja; Boc Marko; Ocvirk Janja
    Bevacizumab after first line treatment in malignant glioma
    2011
  27. Popović Mara
    Oligodendroglioma
    [(Oligodendroglioma)]
    2013
  28. Glavan Matic; Lanišnik Boštjan; Šeruga Tomaž; Rebol Janez
    Sinonazalni paragangliom
    [Sinonasal paraganglioma]
    2012
  29. Jovčevska Ivana; Zupanec Neja; Kočevar Nina; Cesselli Daniela; Podergajs Neža; Limbäck-Stokin Clara; Myers Michael P.; Muyldermans Serge; Hassanzadeh Ghassabeh Gholamreza; Motaln Helena; Ruaro Maria Elisabetta; Bourkoula Evgenia; Lah Turnšek Tamara; Komel Radovan
    TRIM28 and [beta]-actin identified via nanobody-based reverse proteomics approach as possible human glioblastoma biomarkers
    2014
  30. Mesti Tanja; Savarin Philippe; Triba Mohamed N.; Ocvirk Janja; Banissi Claire; Carpentier Antoine F.
    Metabolic impact of anti-angiogenic agents on glioma cells
    2014
  31. Matjašič Alenka; Tajnik Mojca; Popović Mara; Matos Boštjan; Boštjančič Emanuela; Glavač Damjan
    Distinctive expression profiles of lncRNAs in glioma subtypes
    2014
  32. Matjašič Alenka; Tajnik Mojca; Popović Mara; Matos Boštjan; Boštjančič Emanuela; Glavač Damjan
    Glioma subtype-associated lncRNAs and lncRNA-related miRNAs expression patterns
    2014
  33. Perić Barbara; Pohar-Marinšek Živa; Škrbinc Breda; Marolt-Mušič Maja; Žagar Ivana; Hočevar Marko
    A patient with a painless neck tumour revealed as a carotid paraganglioma
    2014
  34. Carpentier Antoine F.; Mesti Tanja; Banissi Claire; Savarin Philippe; Triba Mohamed N.; Ocvirk Janja
    Metabolic profiling of antiangiogenic agents on glioma cells
    2014
  35. Mesti Tanja; Savarin Philippe; Triba Mohamed N.; Le Moyec Laurence; Ocvirk Tanja; Banissi Claire; Carpentier Antoine F.
    Metabolic impact of anti-angiogenic agents on U87 glioma cells
    2014
  36. Primon Monika; Lah Turnšek Tamara
    Učinek arzenovega trioksida in utišanja katepsina L ter vpliv mezenhimskih matičnih celic na celice glioblastoma
    2014
  37. Podergajs Neža; Lah Turnšek Tamara
    Vloga signalnih poti EGFR in FGFR ter novih označevalcev pri glioblastomskih matičnih celicah
    2013
  38. Suárez Carlos; Rodrigo Juan P.; Mendenhall William M.; Hamoir Marc; Silver Carl E.; Grégoire Vincent; Strojan Primož; Neumann Hartmut P. H.; Obholzer Rupert; Offergeld Christian; Langendijk Johannes A.; Rinaldo Alessandra; Ferlito Alfio
    Carotid body paragangliomas
    2014
  39. Tajnik Mojca; Glavač Damjan; Ule Jernej; Volavšek Metka
    Izražanje genov in vpliv polimorfizmov v intronskih regijah na regulacijo alternativnega izrezovanja pri malignih tumorjih
    [Gene expression and influence of intronic sequence polymorphisms on alternative splicing regulation in malignant tumors]
    2013
  40. Strojnik Tadej; Šmigoc Tomaž; Lah Turnšek Tamara
    Prognostic value of erythrocyte sedimentation rate and C-reactive protein in the blood of patients with glioma
    2014
  41. Mesti Tanja; Savarin Philippe; Triba Mohamed N.; Ocvirk Janja; Banissi Claire; Carpentier Antoine F.
    NMR-based metabolomics profiling for identification of bevacizumab effect on U87 cells
    2013
  42. Bregant Tina; Benedik-Dolničar Majda
    Imaging anaplastic oligodendroglioma by difussion tensor imaging analysis
    2013
  43. Bregant Tina; Benedik-Dolničar Majda
    Why imaging anaplastic oligodendroglioma by diffusion tensor imaging analysis
    2013
  44. Jovčevska Ivana; Kočevar Nina; Komel Radovan
    Glioma and glioblastoma how much do we (not) know? (Review)
    2013
  45. Obrez Mateja; Motaln Helena; Tajnšek Urška; Lah Turnšek Tamara
    Vloga matičnih celic pri napredovanju in zdravljenju glioma
    [#The #role of stem cells in glioma progression and therapy]
    2013
  46. Motaln Helena; Lah Turnšek Tamara
    Harnessing systems biology approaches to study direct MSC and glioma (stem) cell interactions
    2013
  47. Perić Barbara; Pohar-Marinšek Živa; Škrbinc Breda; Marolt-Mušič Maja; Žagar Ivana; Hočevar Marko
    Paragangliom kot zasevek
    2012
  48. Popović Mara
    Oligodendrogliom
    [(Oligodendroglioma)]
    2012
  49. Volavšek Metka; Popović Mara
    Anaplastic oligodendroglioma metastasized to extraneural sites
    2012
  50. Hayat MA
    Tumors of the central nervous system: astrocytoma, medulloblastoma, retinoblastoma, chordoma, craniopharyngioma, oligodendroglioma, and ependymoma; vol 8
    2012
  51. Gregorc Marko
    V Piranu o učinkovitejšem diagnosticiranju možganskih tumorjev: v Piranu je na Morski biološki postaji potekalo srečanje partnerjev projekta GLIOMA. Projekt je namenjen raziskovanju možganskih tumorjev
    2012
  52. Rajčević Uroš
    A rodent brain orthotopic model to study human malignant glioma
    2011
  53. Motaln Helena; Koren Ana; Ramšak Živa; Gruden Kristina; Lah Tamara T
    Glioma heterogeneity reflected in vitro in the co-cultured glioma (stem) cell lines
    2012
  54. Smrdel Uroš; Strojnik Tadej
    Obravnava bolnika z nizkomalignim gliomom
    2011
  55. Strojnik Tadej
    Prognostic significance of immunohistochemical markers in glioma patients
    2011
  56. Kasper Burkhard S; Struffert Tobias; Kasper Ekkehard M; Lorber Bogdan
    18Fluoroethyl-L-tyrosine-PET in long-term epilepsy associated glioneuronal tumors
    2011
  57. Vranič Andrej
    New developments in surgery of malignant gliomas
    2011
  58. Vrabec Matej
    Magnetno resonančno slikanje z difuzijskimi tenzorji pri oligodendrogliomih
    2011
  59. Ardebili Seyed Y; Zajc Irena; Gole Boris; Campos Benito; Herold-Mende Christel; Drmota Sara; Lah Tamara T
    CD133/prominin1 is prognostic for GBM patient's survival, but inversely correlated with cysteine cathepsine' expression in gliobastoma derived spheroids
    [CD133/prominin1 je prognostičen za preživetje bolnikov z glioblastoma, vendar obratno korelira z izražanjem cisteinskih katepsinov]
    2011
  60. Warnke Peter C
    31-letna ženska s transformiranim gliomom nizke stopnje malignosti
    [A 31-year-old woman with a transformed low-grade glioma]
    2010
  61. Koršič Marjan
    Obravnava nizkomalignih gliomov
    2010
  62. Bregant T; Jugović D; Benedik-Dolničar M
    Anaplastic oligodendroglioma in an 11-year-old boy with suspected Li-Fraumeni syndrome
    2011
  63. Strojnik Tadej; Kavalar Rajko; Barone Tara A.; Plunkett Robert J.
    Experimental model and immunohistochemical comparison of U87 human glioblastoma cell xenografts on the chicken chorioallantoic membrane and in rat brains
    2010
  64. Anonymous ;
    Skrivnost tumorskih matičnih celic: doktor molekularne biologije Uroš Rajčevič o raziskovanju gliomov
    2010
  65. Skitek Petra; Stirn-Kranjc Branka
    Razširjeni gliom vidne poti pri najstniku
    [Extensive optic pathway glioma in a teenager]
    2010
  66. Rajčević Uroš; Petersen Kjell; Knol Jaco C; Loos Maarten; Bougnaud Sebastian; Miletic Hrvoje; Wang Jian; Bjerkvig Rolf; Jimenez Connie R; Niclou Simone P
    Molecular variations in tumor-host interactions between invasive and angiogenic phenotype in high-grade gliomas
    2009
  67. Šutar Tina; Knežević Miomir; Rajčević Uroš; Kreft Marko
    Primerjava tumorskih matičnih celic gliomov z normalnimi nevroepiteljiskimi matičnimi celicami na ravni informacijske RNA (mRNA)
    [Comparison between gliomas tumor stem cells and neuroepithelium stem cells on a messenger RNA (mRNA) basis]
    2010
  68. Simšič Marija Majda; Hafnar Darja
    Radioterapija malignih gliomov
    [Radiotherapy of malignant glioma]
    2010
  69. Gole Boris
    Izražanje cisteinskih katepsinov in njihovih endogenih inhibitorjev v glioblastomih in njihovih izvornih celicah
    2009
  70. Velnar Tomaž; Smrdel Uroš; Popović Mara; Bunc Gorazd
    Genetic markers in oligodendroglial tumours
    2010
  71. Ocvirk Janja
    Zaviralci angiogeneze v zdravljenju možganskih tumorjev
    2009
  72. Lah-Turnšek Tamara
    Towards novel prognosti markers for reccurent meningioma
    2009
  73. Anonymous ;
    Programme and abstracts of the Glioma invasion forum; 2009 Sep 10-12; Piran
    2009
  74. Rajčević Uroš; Bougnaud Sebastien
    iTRAQ based proteomic profiling reveals increased metabolic activity and cellular crosstalk in angiogenic compared to invasive glioblastoma phenotype
    2009
  75. Motaln Helena; Duran-Alonso Maria Beatriz; Schnichor Christian; Lah Tamara T
    Human measenchymal stem cells after the behaviour of U87 glioma cells
    2009
  76. Pucer Anja; Castino Roberta; Mirković Bojana; Falnoga Ingrid; Šlejkovec Zdenka; Isidoro Ciro; Lah Tamara T
    Mechanism of Trisenox (As2O3) cytotoxicity in GBM treatment
    2009
  77. Strojnik Tadej; Kavalar Rajko; Zajc Irena; Diamandis Eleftherios P; Oikonomopoulou Katerina; Lah Turnšek Tamara
    Prognostic impact of CD68 and kallikrein 6 in human glioma
    2009
  78. Rajčević Uroš; Knol Jaco C; Loos Maarten; Li KaWan; Klychnikobv Oleg; Bjerkvig Rolf; Petersen Kjell; Pham Thang V; Jimenez Connie R; Niclou Simone P
    Addressing the angiogenic switch by studying tumor-host interactions in a model of glioma
    2008
  79. Volavšek Metka; Lamovec Janez; Popović Mara
    Extraneural metastases of anaplastic oligodendroglial tumors
    2009
  80. Strojnik Tadej; Kavalar Rajko; Zajc Irena
    Immunohistochemical detection and possible prognostic value of CD68 and Kallikrein 6 expression in human glioma
    2008
  81. Terzis A Jorge A; Niclou Simone P; Rajčević Uroš; Danzeisen Claude; Bjerkvig Rolf
    Cell therapies for glioblastoma
    2006
  82. Enger Per Oyvind; Sakariassen Per; Prestegaarden Lars; Niclou Simone; Rajčević Uroš; Terzis AJA; Bjerkvig Rolf
    Angiogenesis independent growth mediated by glioma stem cells
    2006
  83. Skitek Petra; Stirn-Kranjc Branka
    Extensive optic pathway glioma in a teenager - a case report
    [Razširjeni gliom vidne poti pri najstniku - prikaz primera]
    2008
  84. Lah-Turnšek Tamara; Duran-Alonso Beatriz M; Gole Boris; Kenig Saša; Pucer Anja; Ardebili Youssuf; Dolenc Vincenc
    SIgnalling of the lysosomal proteases cathepsins B and L in regulating glioma progression
    2008
  85. Duran-Alonso Maria Beatriz; Gole Boris; Kenig Saša; Pucer Anja; Mueller Margareta M; Ardebili Sayed Yousef; Dolenc Vinko; Lah-Turnšek Tamara
    Altered expression of cysteine cathepsins and matrix metallo-proteases (MMP2 and MMP9) in brain tumors differentially affect glioma progression
    2008
  86. Gole Boris; Duran-Alonso Maria Beatriz; Lah Tamara T
    Differential expression of cysteine cathepsins and their endogenous inhibitors in invading versus non-invading glioma cells
    2007
  87. Strojnik Tadej; Kavalar Rajko; Lah Turnšek Tamara; Staubar Rozalija; Zajc Irena
    Proučevanje mehanizmov invazivnosti človeškega glioma na modelu v podganah: zaključno poročilo o rezultatih raziskovalnega projekta
    2007
  88. Gole Boris; Duran-Alonso Beatriz M; Kenig Saša; Zajc Irena; Pucer Anja; Lah-Turnšek Tamara
    Differential expression of cathepsin proteases in invading versus non-invading glioma cells
    2007
  89. Todorović V; Duran-Alonso MB; Lah TT
    The effect of extracellular matrix proteins on resistance to apoptosis and cathepsin B and L expression in glioma cell lines
    2007
  90. Prestor Borut
    Dysplastic gangliocytoma of the cerebellum (Lhermitte-Duclos disease)
    2006
  91. Šega Saša; Horvat Alenka; Popović Mara
    Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-beta treated multiple sclerosis patients: report of two cases
    2006
  92. Strojnik Tadej; Kavalar Rajko; Lah Tamara T
    Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains
    2006
  93. Parker Katherine A; Pilkington Geoffrey J
    Apoptosis of human malignant glioma-derived cell cultures treated with clomipramine hydrochloride, as detected by Annexin-V assay
    [Klomipramin hidroklorid in ugotavljanje apoptoze na celičnih kulturah humanih malignih gliomov s pomočjo pretočne citometrije ob uporabi Annexina-V]
    2006
  94. Pilkington Geoffrey J; Akinwunmi James; Amar Sabrina
    The role of tricyclic drugs in selective triggering of mitochondrially-mediated apoptosis in neoplastic glia: a therapeutic option in malignant glioma?
    [Pomen tricikličnih zdravil pri selektivnem proženju mitohondrijske apoptoze pri neoplastični gliji. Nova možnost zdravljenja malignih gliomov?]
    2006
  95. Slowinski Jerzy; Bierzynska-Macyszyn Grazyna; Mazurek Urszula; Widel Maria; Latocha Malgorzata; Stomal Monika; Snietura Miroslaw; Mrowka Ryszard
    Cytokinesis-block micronucleus assay in human glioma cells exposed to radiation
    2004
  96. Berginc Gašper; Glavač Damjan
    Microsatellite instability and loss of heterozygosity as clinically important molecular markers in different tumours
    [Mikrosatelitna nestabilnost in izguba heterozigotnosti kot klinično pomembna molekularna označevalca pri različnih tumorjih]
    2005
  97. Strojnik Tadej; Kavalar Rajko; Trinkaus Miha; Lah Tamara T
    Cathepsin L in glioma progression: comparison with cathepsin B
    2005
  98. Lah Tamara T; Zajc Irena; Strojnik Tadej; Kenig Saša; Caserman Simon; Trinkaus Miha; Martin Pierre-Marie
    Multifunctional cathepsin L as potential target of cancer therapy
    2005
  99. Žagar Ivana
    Nuklearnomedicinske implikacije primene obeleženih derivata benzilgvanidina
    1994
  100. Strojnik Tadej; Trinkaus Miha; Kavalar Rajko; Martin Pierre-Marie; Lah-Turnšek Tamara
    Cathepsin L in glioma and meningioma progression: comparison with cathepsin B
    2005

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics